{"schema_version":"1.0","type":"article","title":"最強生髮藥暴漲 47%， 為什麼可能改寫掉髮治療三十年僵局？","url":"https://drugnews.com.tw/articles/2026-05-04-hair-growth-drug-breakthrough.html","markdown_url":"https://drugnews.com.tw/articles/2026-05-04-hair-growth-drug-breakthrough.md","lang":"zh-Hant","date":"2026-05-04","publish_at":"2026-05-04T10:30:00+08:00","updated_at":"2026-05-04","category":"商業分析系列","topic":"臨床與 CMC","tags":["Veradermics","生髮藥","掉髮治療","口服 minoxidil","皮膚科"],"summary":"Veradermics 的緩釋型口服 minoxidil 讀出正向臨床資料，讓掉髮治療從醫師經驗用藥走向正式新藥開發與市場重估。","key_points":[],"facts":[],"sections":["最強生髮藥暴漲 47%：Veradermics 為什麼可能改寫掉髮治療三十年僵局？","01｜掉髮市場一直很大，只是長期沒有真正的新答案","02｜VDPHL01 真正厲害的地方，是把 minoxidil 的老問題重新工程化","03｜Study 302：真正打動市場的，不只是 p 值，而是「患者有感」","04｜為什麼市場願意給這麼高估值？因為這不是小眾病，而是現金支付的大眾慢病","05｜亞洲與台灣市場的聯想：不是只有 Veradermics，外用與新機制也會被重新定價","結語｜三十年沒有新答案，現在終於有人把老藥做成新故事"],"references":[{"title":"[0]:公開資料＆各公司官網","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"Veradermics, An IPO Stock, Skyrockets On Oral Rogaine Results","source":"Investor's Business Daily","date":"","url":""},{"title":"Veradermics' oral version of Rogaine led to \"rapid and robust hair growth\" for men with pattern hair loss. The recent IPO stock surged.","source":"","date":"","url":""},{"title":"www.investors.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss","source":"","date":"","url":""},{"title":"Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for patte...","source":"","date":"","url":""},{"title":"www.businesswire.com","source":"","date":"","url":""},{"title":"\"Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss\"","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"www.accessdata.fda.gov","source":"","date":"","url":""},{"title":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20834_ROGAINE%20EXTRA%20STRENGTH%20FOR%20MEN%205%25_BIOPHARMR.PDF","source":"","date":"","url":"https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20834_ROGAINE%20EXTRA%20STRENGTH%20FOR%20MEN%205%25_BIOPHARMR.PDF"},{"title":"www.accessdata.fda.gov","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products","source":"FDA","date":"","url":""},{"title":"FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk.","source":"","date":"","url":""},{"title":"www.fda.gov","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"Document","source":"","date":"","url":""},{"title":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026027354/exhibit991-8xk.htm","source":"","date":"","url":"https://www.sec.gov/Archives/edgar/data/1827635/000162828026027354/exhibit991-8xk.htm"},{"title":"www.sec.gov","source":"","date":"","url":""},{"title":"\"Document\"","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：最強生髮藥暴漲 47%， 為什麼可能改寫掉髮治療三十年僵局？","url":"https://drugnews.com.tw/assets/articles/hair-growth-drug-breakthrough/dcard-01.webp"},{"alt":"Dcard 原圖：最強生髮藥暴漲 47%， 為什麼可能改寫掉髮治療三十年僵局？","url":"https://drugnews.com.tw/assets/articles/hair-growth-drug-breakthrough/dcard-02.webp"},{"alt":"Dcard 原圖：最強生髮藥暴漲 47%， 為什麼可能改寫掉髮治療三十年僵局？","url":"https://drugnews.com.tw/assets/articles/hair-growth-drug-breakthrough/dcard-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/hair-growth-drug-breakthrough/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-05-04）。最強生髮藥暴漲 47%， 為什麼可能改寫掉髮治療三十年僵局？。https://drugnews.com.tw/articles/2026-05-04-hair-growth-drug-breakthrough.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-05-04-hair-growth-drug-breakthrough-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}